ExThera Medical

About

ExThera Medical is a biotechnology company based in Martinez, California, focused on developing extracorporeal blood filtration devices to treat severe infections and metastatic cancers. Founded in 2007 through a partnership between Emergence Venture Partners Life Science Incubator and ExThera AB at Sweden’s Karolinska Institute, the company aims to tackle antimicrobial resistance and enhance oncological therapies. The company’s key products include the Seraph® 100 Microbind® Affinity Blood Filter, which effectively removes pathogens and toxins from the bloodstream, and the ONCObind™ Blood Filter, designed to capture circulating tumor cells in patients with stage 4 metastatic cancers. ExThera Medical's technology utilizes chemically bonded heparin on microbeads to mimic human cell receptors, allowing for broad-spectrum adsorption of harmful substances. Their devices are utilized in healthcare facilities across the U.S. and Europe, as well as in military settings for biodefense applications.